ESC 2015 Schedule

Jump to navigation Jump to search

Here is the page we will use to coordinate the TV events at ESC 2015. Open time slots are indicated below in red.

Filming Location: Crowne Plaza London - Dockland, Western Gateway, Royal Victoria Dock, London, E16 1AL, United Kingdom

Click on Date for Detailed Schedule

Monday, March 16, 2015

8:00 AM

OPEN TIME SLOT

8:30 AM

  • Interviewee:Dr. Vivek Reddy
  • Topic:Safety and efficacy of a Leadless pacemaker: results from the LEADLESS II clinical trial
  • Embargo Lift: Sunday, August 30th at 5:38 PM

9:00 AM

OPEN TIME SLOT

9:30 AM

  • Interviewee: Dr. Kazuaki Kaitani (and Dr. Atsushi Kobori)
  • Topic: Efficacy of Antiarrhythmic drugs Short-Term use after catheter ablation for Atrial Fibrillation (EAST-AF) Trial AND Efficacy of adenosine triphosphate guided ablation for atrial fibrillation: UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate (UNDER-ATP) Trial
  • Embargo Lift: Sunday, August 30th at 4:30 PM and Sunday, august 30th at 4:30 PM

10:00 AM

  • Interviewee:Pr. Michel Ovize
  • Topic:Does cyclosporine improve clinical outcomes in STEMI patients? The CIRCUS trial
  • Embargo Lift: Sunday, August 30th, at 12:27 PM

10:30 AM (PENDING)

  • Interviewee:Dr. Luigi Di Biase
  • Topic:Effect of empirical left atrial appendage isolation on long-term procedure outcome in patients with long-standing persistent atrial fibrillation undergoing catheter ablation: results from the BELIEF Trial
  • Embargo Lift:Sunday March 15, 2015 at 9:00AM

11:00 AM

  • Interviewee:Dr. Marc Gillinov
  • Topic:Effectiveness of Surgical Ablation of Atrial Fibrillation during Mitral Valve Surgery: A Randomized Clinical Trial from the Cardiothoracic Surgical Trials Network
  • Embargo Lift:Monday March 16, 2015 at 8:15AM

11:30 AM

  • Interviewee:Dr. Rajeev K. Pathak
  • Topic:Long-Term Effect of Goal Directed Weight Management on an Atrial Fibrillation Cohort: A 5-Year Follow-Up Study (LEGACY Study)
  • Embargo Lift:Monday March 16, 2015 at 8:30AM

12:00 PM

12:30 PM

  • Interviewee:Dr. Rino Sardella
  • Topic:ACC 2015 Wrap-Up in Italian

1:00 PM

  • Interviewee:Dr. Hisao Ogawa
  • Topic:ACC 2015 Wrap-Up in Japanese

1:30 PM

  • Interviewee:Dr. Susheel Kodali
  • Topic:Early Clinical and Echocardiographic Outcomes with the SAPIEN 3 Transcatheter Aortic Valve Replacement System in Inoperable, High-Risk and Intermediate-Risk Aortic Stenosis Patients
  • Embargo Lift:Sunday March 15, 2015 at 11:15AM

2:00 PM

2:30 PM

  • Interviewee:Dr. Pamela S. Douglas
  • Topic:A Randomized Comparison of Anatomic versus Functional Diagnostic Testing Strategies in Symptomatic Patients with Suspected Coronary Artery Disease: Results from the PROMISE Trial (PROspective Multicenter Imaging Study for Evaluation of chest pain)
  • Embargo Lift:Saturday March 14, 2015 at 9:05AM

3:00 PM

  • Interviewee:Dr. Marco Valgimigli
  • Topic:Transradial Versus Transfemoral Access In Patients With Acute Coronary Syndromes Undergoing Invasive Management: Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation Of Angiox (matrix) Access Site Program&Bivalirudin Infusion Compared To Unfractionated Heparin In Patients With Acute Coronary Syndromes Undergoing Invasive Management: Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation Of Angiox (matrix) Anti-thrombin Program
  • Embargo Lift:Monday March 16, 2015 at 11:00AM&Monday March 16, 2015 at 11:15AM, respectively

3:30 PM

  • Interviewee:Dr. Marc Steven Sabatine
  • Topic:Prevention of Cardiovascular Events in Patients with Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS) - Thrombolysis in Myocardial Infarction (TIMI) 54 & Effect of the PCSK9 Inhibitor Evolocumab on Cardiovascular Outcomes
  • Embargo Lift:Saturday March 14, 2015 at 9:30AM & Sunday March 15, 2015 at 8:00AM, respectively

4:00 PM

  • Interviewee:Dr. Roxana Mehran
  • Topic:A Randomized, Open-Label, Multi-Center, Active-Controlled, Parallel Group Study To Determine the Efficacy and Safety of the REG1 Anticoagulation System Compared to Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention
  • Embargo Lift:Sunday March 15, 2015 at 8:30AM

4:30 PM

  • Interviewee:Dr. Thomas Engstrøm
  • Topic:The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: PRImary PCI in MULTIvessel Disease
  • Embargo Lift:Monday March 16, 2015 at 11:30AM

5:00 PM

  • Interviewee:Prof. Dr. Sigmund Silber
  • Topic:ACC 2015 Wrap-Up in German

Tuesday, March 17, 2015

8:00 AM

8:30 AM

9:00 AM

9:30 AM

10:00 AM

10:30 AM

11:00 AM

11:30 AM

12:00 PM

12:30 PM

1:00 PM

1:30 PM

2:00 PM

2:30 PM

3:00 PM

3:30 PM

4:00 PM

4:30 PM